Critical appraisal:Berry MF, D'Amico TA, Onaitis MW, Kelsey CR 2014

From Cancer Guidelines Wiki

Critical Appraisal

Article being appraised

Berry MF, D'Amico TA, Onaitis MW, Kelsey CR. Thoracoscopic approach to lobectomy for lung cancer does not compromise oncologic efficacy. Ann Thorac Surg 2014 Jul;98(1):197-202 Available from: http://www.ncbi.nlm.nih.gov/pubmed/24820392.


Applicable clinical question

Key Facts

Study Design

case-control study

Study aims:

To compare survival between VATS and thoracotomy approaches to lobectomy for non-small cell lung cancer

Number of Patients:

560

Reported outcome(s):

5 year overall survival

Results of outcome(s):

5 year overall survival was similar for both groups; VATS 60.7% versus thoracotomy 54.8%, p= 0.5

Includes an economic evaluation

no

Evidence ratings

Level of evidence

III-2

Risk of bias
High risk of bias Comments: Please replace this text and include any additional comments in regards to your quality rating

Risk of bias assessment: case-control study

Subject selection
Cases
Highly selected or not described (e.g. single-institution study)
Adequacy of case definition
Taken from medical records, self report without independent validation
Controls
Selected group (e.g. hospital controls)
Comparability of groups on demographic characteristics and important potential confounders
Comparable (or matched)
Ascertainment of exposure/treatment
No or not described
Follow-up complete and all patients included in the analysis?
Complete response
Size of effect
3 Reason for decision: Please replace this text and briefly describe the reasons for your rating
Relevance of evidence
1 Additional comments: Please replace this text and briefly describe the reasons for your rating
Result of appraisal

Jutta's tick icon.png Included




Completed by

Associate Professor Gavin Wright MD FRACS PhD


Jutta's tick icon.png This appraisal has been completed.


Article
Berry MF, D'Amico TA, Onaitis MW, Kelsey CR. Thoracoscopic approach to lobectomy for lung cancer does not compromise oncologic efficacy. Ann Thorac Surg 2014 Jul;98(1):197-202 Available from: http://www.ncbi.nlm.nih.gov/pubmed/24820392.
Assigned to
User:Gavin.wright
Topic area
Guidelines:Lung cancer/Treatment/Non-small-cell stage I operable
Clinical question
Form
Form:Critical appraisal


Section below only relevant for Cancer Council Project Officer

Edit appraisal assignment